Chemical Structure : FG-2101
CAS No.: 2919723-66-1
Catalog No.: PC-24393Not For Human Use, Lab Use Only.
FG-2101 (FG2101) is a potent, in vivo active, non-hydroxamate inhibitor of LpxC with IC50 of 1 nM, exhibits exquisite selectivity over other bacterial and human metalloenzymes (>10,000-fold).
Packing | Price | Stock | Quantity |
---|---|---|---|
2 mg | $288 | In stock | |
5 mg | $488 | In stock | |
10 mg | $788 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
FG-2101 (FG2101) is a potent, in vivo active, non-hydroxamate inhibitor of LpxC with IC50 of 1 nM, exhibits exquisite selectivity over other bacterial and human metalloenzymes (>10,000-fold).
FG-2101 exhibits potent activity against most Enterobacterales, including Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter, Citrobacter, Salmonella, Shigella, and Campylobacter spp., along with biothreat pathogens Francisella tularensis and Yersinia pestis.
FG-2101 is efficacious in multiple animal models of Gram-negative infection including drug-resistant strains via IV and oral routes of administration, does not display preclinical toxicity observed with previous hydroxamate-based inhibitors.
M.Wt | 589.59 | |
Formula | C30H32N5O6P | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
3-Azetidinecarbonitrile, 1-[(2S)-3-[1,6-dihydro-6-oxo-5-(phosphonooxy)-4-pyrimidinyl]-2-[4-[2-[4-(4-morpholinylmethyl)phenyl]ethynyl]phenyl]propyl]- |
1. Patent WO2023055686 A1.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright